Is there any place for oral anti-restenotic treatment in the era of drug eluting stents?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 16230428.
- Also identified by PMC identifier 1769181.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Are drug eluting stents destined to become the standard of care for all patients undergoing percutaneous coronary intervention, or are alternative therapeutic approaches preferable under certain circumstances?
Medical subject headings
- Anticoagulants
- Coronary Restenosis
- Stents